5.40
+2.08%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Basel Medical Group
Its shares trade under the ticker BMGL. It has been listed since 25 February 2025. In the fiscal year to 30 June 2025, it reported revenue of SGD 11.3m and a net loss of SGD 12.1m. At that date it held total assets of SGD 16.9m and shareholders' equity of SGD 4.9m.
Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Ltd. The company provides a wide spectrum of general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, and more. Its services include orthopedic treatments and surgery, rehabilitative therapy, and neurosurgical care. Its orthopedic treatments and surgery include non-surgical treatments, such as medications, injections, splinting and physiotherapy, and surgical orthopedic procedures, including minimally invasive treatments to complex surgeries. Its rehabilitative therapy provides in-house physiotherapy treatments, including post-surgery rehabilitation, as well as sports therapy. Its neurosurgical care covers treatments involving spinal and brain conditions, from headaches and brain tumors to spinal issues, aneurysms and strokes.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 25 Feb 2025
- Website
- baselmedical.com ↗
- Head office
- 600 NORTH BRIDGE ROAD, #12-02/03, SINGAPORE, U0, 188778
- Incorporated in
- D8
- Classification
- Services-Offices & Clinics of Doctors of Medicine
- Filer status
- Non-accelerated filer<br>Emerging growth company
Leadership
Pay as last reported
- Mr. Wai Man CheungChief Executive Officer, Director
- Ms. Jianing LuChief Financial Officer, Director
- Dr. Yen Feng ChhoaChief Health Officer
- Mr. Wee Keong TeoChief Partnership Officer
- Mr. Tony ChenIndependent Director
- Mr. Paul FreudenthalerIndependent Director
- Mr. Kwek Yoon SoongIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Basel Medical Group Ltd. offers comprehensive orthopedic services including knee/hip replacements in Singapore.
- The company provides minimally invasive orthopedic procedures and sports medicine services in the Health Care sector.
- Basel Medical Group Ltd. delivers neurosurgical care for spinal and brain conditions in Singapore.
Weaknesses
- Basel Medical Group Ltd. is a newly listed company on 25 February 2025 in Singapore.
- The company operates solely in the Health Care sector without diversification.
- Basel Medical Group Ltd. has no international presence beyond Singapore.
Opportunities
- Expanding orthopedic services in Singapore's growing Health Care market.
- Increasing demand for minimally invasive procedures in the Health Care industry.
- Growing need for neurosurgical care in Singapore's aging population.
Threats
- Competition from established orthopedic providers in Singapore's Health Care sector.
- Regulatory changes affecting medical services in Singapore's Health Care industry.
- Economic downturns impacting healthcare spending in Singapore.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.